MRD assessment

DIAGNOSTIC_TEST2 trials

Sponsors

Rajshekhar Chakraborty, MD, Gruppo Italiano Malattie EMatologiche dell'Adulto

Conditions

AML, AdultMinimal Residual DiseaseMyeloma

Unknown Phase

Non-invasive MRD Assessment in Multiple Myeloma

CompletedNCT05625971

Rajshekhar Chakraborty, MDMyeloma

Start: 2022-09-14End: 2025-12-15Updated: 2026-01-07

Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax

Not yet recruitingNCT06090786

Gruppo Italiano Malattie EMatologiche dell'AdultoAML, Adult, Minimal Residual Disease

Start: 2024-07-31End: 2027-07-31Target: 225Updated: 2024-04-10